Haya Therapeutics’ CHF 18 Million Seed Round

Federica Tiefenthaler Europe, Europe Legal Chronicle
Tagged:

VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round.HAYA Therapeutics SA, a company developing precision medicines that target tissue and cell-specific…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here